AMRI-59 is a potent inhibitor of PrxI and can be used in the study of parasitic infections; it exhibits significant antitumor activity by increasing cellular ROS levels, leading to activation of mitochondrial and apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathways, thereby inducing apoptosis in A549 human lung adenocarcinoma cells; it shows no apparent acute toxicity.